Synaptogenix, Inc. (NASDAQ:SNPX – Get Rating) was the target of a significant decline in short interest in the month of May. As of May 15th, there was short interest totalling 221,100 shares, a decline of 31.3% from the April 30th total of 321,800 shares. Approximately 4.8% of the shares of the company are short sold. […]